Previous Close | 0.6250 |
Open | 0.6950 |
Bid | 0.6200 x N/A |
Ask | 0.7550 x N/A |
Day's Range | 0.6650 - 0.6950 |
52 Week Range | 0.6200 - 3.6000 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Sol-Gel Technologies ( NASDAQ:SLGL ) Full Year 2023 Results Key Financial Results Net loss: US$27.2m (loss widened by...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Sol-Gel Technologies fair value estimate is US$1.87 Sol-Gel...
Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies are part of the Zacks Industry Outlook article.